Axsome Therapeutics, Inc.

AXSM·NASDAQ·$234.20Share Price as of 11/2·$12BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/10/26 10-QQ1 ended 03/31/2605/04/26 10-KFY 202502/23/26 10-QQ3 ended 09/30/2511/03/25 10-QQ2 ended 06/30/2508/04/25

Disclosures

8-KCurrent report08/10/26 8-KCurrent report07/15/26 8-KCurrent report06/09/26 8-KCurrent report06/09/26 8-KCurrent report06/03/26

Prospectuses and Registrations

S-3ASRAutomatic shelf registration11/03/25 S-8Registration of securities for employees08/07/25 S-8Registration of securities for employees08/05/24 424B5Prospectus supplement06/29/23 424B5Prospectus supplement06/28/23

Proxies

DEF 14ADefinitive proxy04/24/26 DEFA14AAdditional proxy materials04/24/26 DEF 14ADefinitive proxy04/25/25 DEFA14AAdditional proxy materials04/25/25 DEF 14ADefinitive proxy04/26/24

Ownership

144Proposed sale of securities09/03/26 Form 4Insider transaction09/03/26 Form 4Insider transaction08/07/26 144Proposed sale of securities08/06/26 144Proposed sale of securities08/05/26

Other

ARSAnnual report to shareholders04/24/26 ARSAnnual report to shareholders04/25/25 ARSAnnual report to shareholders04/26/24 ARSAnnual report to shareholders04/21/23 SEC STAFF LETTERSEC staff letter04/19/21